Type 2 Diabetes Mellitus Patients' Characteristics and Management by General Practitioners and Endocrinologists

CompletedOBSERVATIONAL
Enrollment

907

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

April 15, 2019

Study Completion Date

April 15, 2019

Conditions
Type 2 Diabetes Mellitus
Trial Locations (20)

D1690R00037

Research Site, Belgorod Region, Shebekino

Research Site, Belgorod Region, Volokonovsky R-n, P. Volokonovka

Research Site, Gis-Khrustalny

Research Site, Izhevsk

Research Site, Kazan'

Research Site, Lipetsk

Research Site, N. Novgorod Region

Research Site, Nizhny Novgorod

Research Site, Novomoskovsk

Research Site, Novosibirsk

Research Site, Perm

Research Site, Ryazan

Research Site, Saint Petersburg

Research Site, Samara

Research Site, Tambov Region

Research Site, Volzhsk

Research Site, Voronezh

Research Site, Voronezh Region, Novovoronezh

Research Site, Yaroslavl

Research Site, Yoshkar-Ola

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY